A trial looking at treatment for germ cell tumours (AGCT1531)
This trial is looking at follow up and different treatment options for people with germ cell tumours to help improve treatment results and quality of life.
This trial is looking at follow up and different treatment options for people with germ cell tumours to help improve treatment results and quality of life.
This study is using an online survey to find out what is important to people about the design and delivery of care.
Mortality rates for testicular cancer in the UK are highest in males aged 90+ (2017-2019).
Each year almost 3 in 20 of all testicular cancer deaths (13%) in the UK are in males aged 75 and over (2017-2019).
This study is looking at biomarkers in blood, urine, poo, semen, breath and tissue samples of people with prostate, kidney, bladder and testicular cancer.
Since the early 1970s, testicular cancer mortality rates have decreased by more than four-fifths (82%) in males in the UK (2017-2019).
Over the last decade, testicular cancer mortality rates have remained stable in males in the UK (2017-2019).
Mortality rates for testicular cancer in the UK are highest in males aged 50 to 54 (2014-2016).
The trial is for men and teenage boys (14 years or older) whose germ cell tumours have come back or treatment has stopped working.
There are around 65 testicular cancer deaths in the UK every year, that's more than 1 every week (2017-2019).
Testicular cancer is the not among the 20 most common causes of cancer death in males in the UK, accounting for less than 1% of all cancer deaths in males in the UK (2017-2019).
Testicular cancer accounts for less than 1% of all cancer deaths in females and males combined in the UK (2017-2019).
Since the early 1990s, testicular cancer incidence rates have increased by more than a quarter (27%) in males in the UK (2017-2019).
Over the last decade, testicular cancer incidence rates have increased by around a twentieth (6%) in males in the UK (2017-2019).
Incidence rates for testicular cancer in the UK are highest in males aged 30 to 34 (2017-2019).
Each year less than a twentieth (1%) of all new testicular cancer cases in the UK are diagnosed in males aged 75 and over (2017-2019).